Home > Boards > US Listed > Biotechs > Minerva Neurosciences, Inc. (NERV)

Looking forward to the conference call tomorrow.

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
penny.dreamer Member Profile
 
Followed By 28
Posts 1,620
Boards Moderated 1
Alias Born 02/11/18
160x600 placeholder
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 10/14/2020 5:22:53 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 10/14/2020 5:21:42 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 10/14/2020 5:19:59 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 10/14/2020 5:19:07 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 10/14/2020 5:17:34 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 10/14/2020 4:59:43 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 9/11/2020 5:14:30 PM
Minerva Neurosciences to Present at H.C. Wainwright 22nd Annual Global Investment Conference GlobeNewswire Inc. - 9/9/2020 8:30:10 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/8/2020 7:14:11 AM
Minerva Neurosciences to Present at Citi's 15th Annual BioPharma Virtual Conference GlobeNewswire Inc. - 9/2/2020 8:30:10 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 8/17/2020 4:33:48 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 8/17/2020 4:32:52 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 8/17/2020 4:31:37 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 8/17/2020 4:31:16 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 8/17/2020 4:29:50 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 8/17/2020 4:29:04 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 8/17/2020 4:27:48 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 8/17/2020 4:26:33 PM
Minerva Neurosciences to Present at JMP Securities CNS Forum GlobeNewswire Inc. - 8/13/2020 8:00:10 AM
Securities Registration: Employee Benefit Plan (s-8) Edgar (US Regulatory) - 8/10/2020 6:10:55 AM
Minerva Neurosciences Reports Second Quarter 2020 Financial Results and Business Updates GlobeNewswire Inc. - 8/3/2020 7:30:10 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 8/3/2020 7:01:32 AM
Minerva Neurosciences to Report Second Quarter 2020 Financial Results and Business Updates on August 3, 2020 GlobeNewswire Inc. - 7/27/2020 8:00:10 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 7/2/2020 5:29:29 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 7/1/2020 5:08:46 PM
penny.dreamer   Thursday, 06/04/20 03:32:35 PM
Re: None
Post # of 157 
Looking forward to the conference call tomorrow.

Minerva Neurosciences will host a conference call and live audio webcast on Friday, June 5, 2020 at 8:30 a.m. Eastern Time to discuss the Phase 3 trial of roluperidone. To participate, please dial 1-877-425-9470 (toll free) or 1-201-389-0878 (toll/international), and refer to conference ID 13703481.


Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences